Actinium Pharmaceuticals Inc. buy melinda
Start price
28.07.17
/
50%
€15.00
Target price
23.10.17
€36.00
Performance (%)
20.80%
End price
23.10.17
€18.12
Summary
This prediction ended on 23.10.17 with a price of €18.12. The prediction had a final performance of 20.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | 13.630% | 13.630% | 2.125% | 36.167% |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% | 17.647% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% | 50.762% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% | 43.940% |
Comments by melinda for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
PHARMA
Actinium Pharmaceuticals, Inc. (NYSE Amex: ATNM) ihre Absicht angekündigt , die Aktien und Optionsscheine in einem öffentlichen Angebot Zeichnungs zu verkaufen. Die Aktien gehandelt werden um 19% auf $ 0,79 auf der Sitzung nach Stunden.
Stopped prediction by melinda for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.66
02.12.18
02.12.18
€21.00
21.01.19
21.01.19
-32.76%
21.01.19
21.01.19
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.46
06.05.16
06.05.16
€57.00
31.08.16
31.08.16
6.41%
31.08.16
31.08.16